Individual results are not guaranteed and may vary from person to person
Insufficient testing The risk of counterfeits Sterility failures and manufacturing impurities Potential drug interactions Unknown long-term effects More peptide safety resources Blog by Dan Burke, former FDA federal agent PSM's submission to the FDA Pharmacy Compounding Advisory Committee July 23-24 meeting
L-Carnitine supplementation may cause mild gastrointestinal symptoms, including nausea, vomiting, abdominal cramps, and diarrhea
248 Multi-purpose wearable devices that have received FDA clearance for use in monitoring sleep parameters intended to inform users of potential sleep apnea risk include the Samsung Galaxy Watch and certain models of the Apple Watch
No shared receptor targets
2, where substantial overlap in the regulation of neurotransmitter signalling by the trace aminergic system exists in both brain and gut compartments, suggesting a potential for therapeutic intervention at both sites via trace aminergic modulation